Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.050
+0.060 (3.02%)
At close: May 16, 2025, 4:00 PM
2.040
-0.010 (-0.49%)
After-hours: May 16, 2025, 4:05 PM EDT
Celularity Employees
Celularity had 120 employees as of December 31, 2023. The number of employees decreased by 105 or -46.67% compared to the previous year.
Employees
120
Change (1Y)
-105
Growth (1Y)
-46.67%
Revenue / Employee
$451,833
Profits / Employee
-$482,433
Market Cap
46.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 120 | -105 | -46.67% |
| Dec 31, 2022 | 225 | 0 | - |
| Dec 31, 2021 | 225 | 63 | 38.89% |
| Dec 31, 2020 | 162 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CELU News
- 7 days ago - Celularity Announces Full Year 2024 Operating and Financial Results - GlobeNewsWire
- 21 days ago - Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees - GlobeNewsWire
- 4 weeks ago - Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - GlobeNewsWire
- 2 months ago - Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products - GlobeNewsWire
- 2 months ago - Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company - GlobeNewsWire
- 5 months ago - Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - GlobeNewsWire
- 5 months ago - Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023 - GlobeNewsWire
- 6 months ago - Celularity Inc. Announces Receipt of Nasdaq Notification - GlobeNewsWire